BridgeBio Pharma (BBIO) EBT Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 7.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.46% |
| Dec 31, 2025 | -10.30% |
| Sep 30, 2025 | -8.37% |
| Jun 30, 2025 | -22.14% |
| Mar 31, 2025 | 15.45% |
| Dec 31, 2024 | -13.82% |
| Sep 30, 2024 | -0.81% |
| Jun 30, 2024 | 10.26% |
| Mar 31, 2024 | 52.42% |
| Dec 31, 2023 | -11.66% |
| Sep 30, 2023 | -10.20% |
| Jun 30, 2023 | -6.47% |
| Mar 31, 2023 | -10.78% |
| Dec 31, 2022 | -22.34% |
| Sep 30, 2022 | -39.56% |
| Jun 30, 2022 | -12.72% |
| Mar 31, 2022 | -45.18% |
| Dec 31, 2021 | -40.37% |
| Sep 30, 2021 | -56.18% |
| Jun 30, 2021 | -44.03% |